New Operations Manager at Biovica

2017-12-05 08:30

Uppsala, December 5, 2017. Biovica has appointed Adam Germunder as new Operations Manager. Adams responsibilities include to build and secure the company’s production capabilities and ensure that they meet regulatory requirements in preparation for the commercialization of DiviTum®.


Adam has experience in production management and process development. He has worked, among other things, to develop and implement new production methods in ISO13485-certified medical technology companies. Adams previous professional experiences include roles such as Production manager at Fiomi Diagnostics where he was responsible for the production processes and from the company Fresenius Kabi. His experience includes planning and building scalable production environments for diagnostic products and ensuring compliance with high regulatory requirements from, among others, the FDA.

"We are very pleased to welcome Adam to our management team and securing important experiences from production, upscaling, and ensuring that production processes meet high regulatory requirements such as the FDA. This experience is very important to Biovica for the forthcoming commercialization of our product DiviTum. DiviTum is the answer for a clear diagnostic need by evaluating the effect of cancer treatments, and is expected to provide great values for patients and society."– Anders Rylander, CEO Biovica


Numbers of patients in studies




Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program